Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Amortization - Intangibles of $183000.0 for Q1 2026, down 99.95% year-over-year from $362.0 million in Q1 2025, and down 78.03% quarter-over-quarter from $833000.0 in Q4 2025.
Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California's Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $183000.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles fell 99.95% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 99.44% YoY), while the FY2025 annual figure was $364.5 million, up 3780.99% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $183000.0, down from $833000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $362.0 million in Q1 2025, with the low at -$4.0 million in Q4 2024.
- The 5-year median for Amortization - Intangibles is $787000.0 (2023), against an average of $26.8 million.
- The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles sank 173.56% in 2024, then soared 26857.71% in 2025.
- Pacific Biosciences Of California's Amortization - Intangibles stood at $183000.0 in 2022, then soared by 2859.56% to $5.4 million in 2023, then tumbled by 173.56% to -$4.0 million in 2024, then surged by 120.91% to $833000.0 in 2025, then slumped by 78.03% to $183000.0 in 2026.
- Business Quant data shows PACB's Amortization - Intangibles at $183000.0 in Q1 2026, $833000.0 in Q4 2025, and $833000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 833,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | 833,000.00 |
| Sep 30, 2025 | 833,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 362.04 Mn |
| Dec 31, 2024 | -3.98 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 741,000.00 |
| Jun 30, 2023 | 183,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | 183,000.00 |